Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2941
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04825873 | A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China | ||
| NCT06487156 | A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | ||
| NCT07608731 | Golcadomide With Pemetrexed, Rituximab, and Dexamethasone for Relapsed and Refractory CNS Lymphomas | ||
| NCT03200977 | Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab | ||
| NCT04477629 | Belatacept in De Novo Heart Transplantation | ||
| NCT05469737 | A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS) | ||
| NCT00000772 | A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals | ||
| NCT04493541 | A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus | ||
| NCT05621096 | Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma | ||
| NCT02134288 | Belatacept for Renal Transplant Recipients With Delayed Graft Function | ||
| NCT00193141 | Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | ||
| NCT03509883 | Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules | ||
| NCT03226756 | Nivolumab in Recurrent and/or Metastatic SCCHN | ||
| NCT00914641 | Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers | ||
| NCT01306942 | Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients | ||
| NCT01790594 | Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation | ||
| NCT00284154 | Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer | ||
| NCT01995266 | Phase III China GT 1b Interferon (IFN) Intolerant Prev Exclude Dual | ||
| NCT03346837 | A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects | ||
| NCT03981094 | A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants | ||
| NCT03459222 | An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread | ||
| NCT04949269 | A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Participants | ||
| NCT02109666 | Long Term Experience With Abatacept in Routine Clinical Practice | ||
| NCT07532902 | A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer | ||
| NCT00438854 | Dasatinib in Relapsed Chronic Lymphocytic Leukemia | ||
| NCT02426866 | Risk of CV Events With EFV vs. EFV-free Regimens | ||
| NCT01940198 | Long-term Atazanavir Experience in a High HIV Caseload Primary Care Practice in Sydney, Australia | ||
| NCT05605782 | A Post-Authorization, Long-term Study of Ozanimod Real-world Safety | ||
| NCT03784040 | Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study. | ||
| NCT00103844 | Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia | ||
| NCT00002307 | A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients | ||
| NCT07422298 | A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants | ||
| NCT03465592 | Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma | ||
| NCT02651363 | Diclofenac 25mg/Paracetamol 500 mg and Diclofenac 50 mg/Paracetamol 500 mg for Patients With Pain | ||
| NCT02667587 | An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) | ||
| NCT03155100 | Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines | ||
| NCT00395018 | Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection | ||
| NCT00130689 | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | ||
| NCT03315468 | French Clinical Datbase of Melanoma Patients (RIC-Mel) | ||
| NCT03335540 | An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment | ||
| NCT04263350 | A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time | ||
| NCT07204418 | A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants | ||
| NCT06361563 | Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada | ||
| NCT01129063 | Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT07636863 | Treatment Patterns and Characteristics of Patients Prescribed Opdivo Qvantig | ||
| NCT01758198 | Abatacept Post-marketing Clinical Study in Japan | ||
| NCT03927105 | Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma | ||
| NCT00703469 | A Study of MDX-1106 to Treat Patients With Hepatitis C Infection | ||
| NCT02257151 | Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects |
